The study's authors examined data from the DANAMI-3 trial, focusing on such outcomes as all-cause mortality, recurrent MI and target vessel revascularization.

Santiago Garcia, MD, lead author of the study and director of the structural heart program at The Christ Hospital in Cincinnati, Ohio, presented new data from the North American COVID-19 STEMI (NACMI) registry at ACC.22. Severity of heart attacks were reduced in vaccinated patients, with zero deaths in vaccinated patients in 2021.

The company's flagship offering uses AI to evaluate 3D images of a patient's heart for signs of atherosclerotic plaque.

The new international consensus document gives detailed recommendations on when to offer genetic testing for patients and their family members. 

The first-in-man study, completed by a team of cardiologists in China, included 10 patients presenting with HFpEF. 

The increased risk of deep vein thrombosis lasts for up to three months, researchers found. 

Joanna Chikwe, MD, founding chair of the department of cardiac surgery at Cedars-Sinai Hospital, compares transcatheter edge-to-edge repair (TEER) to mitral valve surgery for primary mitral regurgitation.

Steven E. Nissen, MD, chief academic officer of the Sydell and Arnold Miller Family Heart, Vascular and Thoracic Institute at the Cleveland Clinic, was the lead author on the Apollo Trial, a late-breaking ACC.22 study evaluating the effectiveness of an mRNA drug to suppress lipoprotein(a).

The agency has maintained the same pay restrictions in its final policy, only covering PET scans if required by a clinical trial protocol.